hibiscuswahine
Senior Member (Voting Rights)
Anurag Adhikari, Janesha Maddumage, Emily M Eriksson, Sarah J Annesley, Victoria A Lawson, Vanessa L Bryant and Stephanie Gras
Med J Aust 2024; 221 (9): S40-S48. || doi: 10.5694/mja2.52456
Published online: 4 November 2024
https://www.mja.com.au/journal/2024...-underlying-post-acute-sequelae-covid-19-pasc
Summary
Med J Aust 2024; 221 (9): S40-S48. || doi: 10.5694/mja2.52456
Published online: 4 November 2024
https://www.mja.com.au/journal/2024...-underlying-post-acute-sequelae-covid-19-pasc
Summary
- Immune dysregulation is a key aspect of post‐acute sequelae of coronavirus disease 2019 (PASC), also known as long COVID, with sustained activation of immune cells, T cell exhaustion, skewed B cell profiles, and disrupted immune communication thereby resulting in autoimmune‐related complications.
- The gut is emerging as a critical link between microbiota, metabolism and overall dysfunction, potentially sharing similarities with other chronic fatigue conditions and PASC.
- Immunothrombosis and neurological signalling dysfunction emphasise the complex interplay between the immune system, blood clotting, and the central nervous system in the context of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection.
- Clear research gaps in the design of PASC studies, especially in the context of longitudinal research, stand out as significant areas of concern.
Attachments
Last edited: